Relationship Between Histone H3 Lysine 9 Methylation, Transcription Repression, and Heterochromatin Protein 1 Recruitment
Overview
Authors
Affiliations
Histone H3 lysine 9 (H3-K9) methylation has been shown to correlate with transcriptional repression and serve as a specific binding site for heterochromatin protein 1 (HP1). In this study, we investigated the relationship between H3-K9 methylation, transcriptional repression, and HP1 recruitment by comparing the effects of tethering two H3-K9-specific histone methyltransferases, SUV39H1 and G9a, to chromatin on transcription and HP1 recruitment. Although both SUV39H1 and G9a induced H3-K9 methylation and repressed transcription, only SUV39H1 was able to recruit HP1 to chromatin. Targeting HP1 to chromatin required not only K9 methylation but also a direct protein-protein interaction between SUV39H1 and HP1. Targeting methyl-K9 or a HP1-interacting region of SUV39H1 alone to chromatin was not sufficient to recruit HP1. We also demonstrate that methyl-K9 can suppress transcription independently of HP1 through a mechanism involving histone deacetylation. In an effort to understand how H3-K9 methylation led to histone deacetylation in both H3 and H4, we found that H3-K9 methylation inhibited histone acetylation by p300 but not its association with chromatin. Collectively, these data indicate that H3-K9 methylation alone can suppress transcription but is insufficient for HP1 recruitment in the context of chromatin exemplifying the importance of chromatin-associated factors in reading the histone code.
Epigenetic regulation of targeted ferroptosis: A new strategy for drug development.
Ouyang S, Zeng Z, He J, Luo L J Pharm Anal. 2025; 14(10):101012.
PMID: 39850234 PMC: 11755343. DOI: 10.1016/j.jpha.2024.101012.
Farrokhi Yekta R, Farahani M, Koushki M, Amiri-Dashatan N Front Oncol. 2024; 14:1481426.
PMID: 39497715 PMC: 11532047. DOI: 10.3389/fonc.2024.1481426.
Dinochromosome Heterotermini with Telosomal Anchorages.
Kwok A, Yan K, Wen S, Sun S, Li C, Wong J Int J Mol Sci. 2024; 25(20).
PMID: 39457094 PMC: 11508785. DOI: 10.3390/ijms252011312.
Yamauchi Y, Shimizu E, Duncan H Int J Mol Sci. 2024; 25(12).
PMID: 38928274 PMC: 11203584. DOI: 10.3390/ijms25126569.
Shi Y, Fu L, Tanizaki Y Mol Cell Endocrinol. 2024; 586:112193.
PMID: 38401883 PMC: 10999354. DOI: 10.1016/j.mce.2024.112193.